Peter Culpepper
This person does not yet have a bio.
Articles by Peter Culpepper
| 6 min read
A
reprint of a commentary from our Cancer Research News site looking at three candidate drugs currently under investigation as intralesional agents for
melanoma treatment
| 6 min read
Despite past safety
concerns, enthusiasm for intralesional cancer therapies is waxing once again, with several companies advancing intralesional treatment candidates for
melanoma
Page 1 of 1 - 2 Total Items
